Keywords: merck, co, wins, male, label, fosamax, food

Merck & Co wins male label for Fosamax

Article | 05 October 2000

Print This

The US Food and Drug Administration has approved an additionalindication for Merck & Co's Fosamax (alendronate), for use in men with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in